Get started
Author

Sophie Gerkens

Observed names: Gerkens, Sophie, S Gerkens, S. Gerkens
ORCID: 0000-0001-6211-3471
Observed ORCID: 0000-0001-6211-3471
OpenAlex ID: A5063513647
Belgium: Health System Review.
2010 · Sophie Gerkens, Sherry Merkur · PubMed · 205
PDF
Pharmaceutical regulation in 15 European countries review.
2016 · Dimitra Panteli, Francis Arickx, et al. · PubMed · 108
Comparison of three instruments assessing the quality of economic evaluations: A practical exercise on economic evaluations of the surgical treatment of obesity
2008 · Sophie Gerkens, Ralph Crott, et al. · International Journal of Technology Assessment in Health Care · 81
Steroid-Free, Tacrolimus-Basiliximab Immunosuppression in Pediatric Liver Transplantation: Clinical and Pharmacoeconomic Study in 50 Children
2008 · Jérémie M. Gras, Sophie Gerkens, et al. · Liver Transplantation · 77
Performance of the Belgian health system: Report 2024
2024 · Sophie Gerkens, Mélanie Lefèvre, et al. · 74
PDF
Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?
2013 · María-Isabel Farfan-Portet, Sophie Gerkens, et al. · The European Journal of Health Economics · 70
PDF
Balancing financial incentives during COVID-19: A comparison of provider payment adjustments across 20 countries
2021 · Ruth Waitzberg, Sophie Gerkens, et al. · Health Policy · 61
PDF
An EQ-5D-5L Value Set for Belgium
2022 · Nicolas Bouckaert, Irina Cleemput, et al. · PharmacoEconomics - Open · 60
PDF
Harms and benefits of screening young people to prevent sudden cardiac death
2016 · Hans Van Brabandt, Anja Desomer, et al. · BMJ · 54
Tackling the COVID-19 pandemic: Initial responses in 2020 in selected social health insurance countries in Europe
2021 · Andrea E. Schmidt, Sherry Merkur, et al. · Health Policy · 36
PDF
Availability and financing of CAR-T cell therapies: A cross-country comparative analysis
2024 · Yulia Litvinova, Sherry Merkur, et al. · Health Policy · 33
Required hospital capacity in 2025 and criteria for rationalisation of complex cancer surgery, radiotherapy and maternity services
2017 · Carine Van de Voorde, Koen Van Den Heede, et al. · 27
An evaluation of managed entry agreements in Belgium: A system with threats and (high) potential if properly applied
2020 · Mattias Neyt, Sophie Gerkens, et al. · Health Policy · 23
PDF
Development of a national position paper for chronic care: Example of Belgium
2013 · Dominique Paulus, Koen Van den Heede, et al. · Health Policy · 17
PDF
A health economic model to assess the cost-effectiveness of pegylated interferon alpha-2a and ribavirin in patients with moderate chronic hepatitis C and persistently normal alanine aminotransferase levels.
2007 · Sophie Gerkens, Myriam Nechelput, et al. · PubMed · 15
Incentives for market penetration of biosimilars in Belgium and in five European countries.
2014 · N Swartenbroekx, Farfan-Portet, et al. · PubMed · 12
A health economic model to assess the cost‐effectiveness of PEG IFN α‐2a and ribavirin in patients with mild chronic hepatitis C
2007 · S. Gerkens, M. Nechelput, et al. · Journal of Viral Hepatitis · 12
Performance of the Belgian health system: Revision of the conceptual framework and indicators set
2023 · Sophie Gerkens, Charline Maertens de Noordhout, et al. · 10
PDF
Performance of the Belgian health system: Report 2019
2019 · Carl Devos, Audrey Cordon, et al. · 9
PDF
How to improve the Belgian process for Managed Entry Agreements? An analysis of the Belgian and international experience
2017 · Sophie Gerkens, Mattias Neyt, et al. · 7
PDF
A comparative analysis of hospital care payments in five countries
2013 · Carine Van de Voorde, Sophie Gerkens, et al. · 6
PDF
Economic evaluation of the use of point-of-care devices in patients with long term oral anticoagulation
2012 · Sophie Gerkens, Jeannine Gailly, et al. · Journal of Thrombosis and Thrombolysis · 6
Barriers and opportunities for the uptake of biosimilar medicines in Belgium
2013 · Isabelle Lepage-Nefkens, Sophie Gerkens, et al. · 5
PDF
Barriers and opportunities for the uptake of biosimilar medicines in Belgium
2013 · Isabelle Lepage-Nefkens, Sophie Gerkens, et al. · 5
PDF
Organisation et financement de la dialyse chronique en Belgique
2010 · Irina Cleemput, Claire Beguin, et al. · 5
PDF
Works count: 171
Citation count: 1,109
H-index: 15
I10-index: 18
Year
Topic
Type